Literature DB >> 21224474

A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing.

Weiyi Feng1, Maria Madajka, Bethany A Kerr, Ganapati H Mahabeleshwar, Sidney W Whiteheart, Tatiana V Byzova.   

Abstract

Angiogenesis alleviates hypoxic stress in ischemic tissues or during tumor progression. In addition to endothelial cell proliferation and migration, the angiogenic process requires bone marrow-derived cell (BMDC) recruitment to sites of neovascularization. However, the mechanism of communication between hypoxic tissues and the BM remains unknown. Using 2 models of hypoxia-induced angiogenesis (ischemic hindlimb surgery and subcutaneous tumor growth), we show that platelet infusion promotes BMDC mobilization into the circulation, BMDC recruitment into growing neovasculature, tumor vascularization, and blood flow restoration in ischemic limbs, whereas platelet depletion inhibits these effects. Thus, platelets are required for BMDC recruitment into ischemia-induced vasculature. Secretion of platelet α-granules, but neither dense granules nor platelet aggregation is crucial for BMDC homing and subsequent angiogenesis, as determined using VAMP-8(-/-), Pearl, and integrin Beta 3(-/-) platelets. Finally, platelets sequester tumor-derived promoters of angiogenesis and BMDC mobilization, which are counterbalanced by the antiangiogenic factor thrombospondin-1. A lack of thrombospondin-1 in platelets leads to an imbalance in proangiogenic and antiangiogenic factors and accelerates tumor growth and vascularization. Our data demonstrate that platelets stimulate BMDC homing in a VAMP-8-dependent manner, revealing a previously unknown role for platelets as key mediators between hypoxic tissues and the bone marrow during angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21224474      PMCID: PMC3083301          DOI: 10.1182/blood-2010-08-304808

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity.

Authors:  Sheng Zheng; Jian Shen; Yang Jiao; Yan Liu; Chunmei Zhang; Min Wei; Shui Hao; Xianlu Zeng
Journal:  Cancer Sci       Date:  2009-03-11       Impact factor: 6.716

2.  Differential mobilization of subsets of progenitor cells from the bone marrow.

Authors:  Simon C Pitchford; Rebecca C Furze; Carla P Jones; Antje M Wengner; Sara M Rankin
Journal:  Cell Stem Cell       Date:  2009-01-09       Impact factor: 24.633

3.  Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.

Authors:  D Lyden; K Hattori; S Dias; C Costa; P Blaikie; L Butros; A Chadburn; B Heissig; W Marks; L Witte; Y Wu; D Hicklin; Z Zhu; N R Hackett; R G Crystal; M A Moore; K A Hajjar; K Manova; R Benezra; S Rafii
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

Review 4.  Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.

Authors:  Jack Lawler
Journal:  J Cell Mol Med       Date:  2002 Jan-Mar       Impact factor: 5.310

5.  Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells.

Authors:  K Hattori; B Heissig; K Tashiro; T Honjo; M Tateno; J H Shieh; N R Hackett; M S Quitoriano; R G Crystal; S Rafii; M A Moore
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

6.  Angiogenesis induced by the injection of peripheral leukocytes and platelets.

Authors:  Toshiro Kobayashi; Kimikazu Hamano; Tao-Sheng Li; Masahiko Nishida; Shigeru Ikenaga; Ken Hirata; Nobuya Zempo; Kensuke Esato
Journal:  J Surg Res       Date:  2002-04       Impact factor: 2.192

7.  Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis.

Authors:  Alexander Zaslavsky; Kwan-Hyuck Baek; Ryan C Lynch; Sarah Short; Jenny Grillo; Judah Folkman; Joseph E Italiano; Sandra Ryeom
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

8.  Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells.

Authors:  David Zisa; Arsalan Shabbir; Michalis Mastri; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-09-16       Impact factor: 3.619

9.  G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models.

Authors:  Farbod Shojaei; Xiumin Wu; Xueping Qu; Marcin Kowanetz; Lanlan Yu; Martha Tan; Y Gloria Meng; Napoleone Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-03       Impact factor: 11.205

10.  Platelets actively sequester angiogenesis regulators.

Authors:  Giannoula Lakka Klement; Tai-Tung Yip; Flavia Cassiola; Lena Kikuchi; David Cervi; Vladimir Podust; Joseph E Italiano; Erin Wheatley; Abdo Abou-Slaybi; Elise Bender; Nava Almog; Mark W Kieran; Judah Folkman
Journal:  Blood       Date:  2008-11-25       Impact factor: 22.113

View more
  34 in total

1.  Inorganic polyphosphate induces accelerated tube formation of HUVEC endothelial cells.

Authors:  Werner E G Müller; Maximilian Ackermann; Shunfeng Wang; Meik Neufurth; Rafael Muñoz-Espí; Qingling Feng; Heinz C Schröder; Xiaohong Wang
Journal:  Cell Mol Life Sci       Date:  2017-08-02       Impact factor: 9.261

2.  Blood platelets contain tumor-derived RNA biomarkers.

Authors:  R Jonas A Nilsson; Leonora Balaj; Esther Hulleman; Sjoerd van Rijn; D Michiel Pegtel; Maudy Walraven; Anders Widmark; Winald R Gerritsen; Henk M Verheul; W Peter Vandertop; David P Noske; Johan Skog; Thomas Würdinger
Journal:  Blood       Date:  2011-08-10       Impact factor: 22.113

Review 3.  Microenvironmental regulation of tumour angiogenesis.

Authors:  Michele De Palma; Daniela Biziato; Tatiana V Petrova
Journal:  Nat Rev Cancer       Date:  2017-07-14       Impact factor: 60.716

4.  Bone marrow-derived cells homing for self-repair of periodontal tissues: a histological characterization and expression analysis.

Authors:  Yan Wang; Lili Zhou; Chen Li; Han Xie; Yuwang Lu; Ying Wu; Hongwei Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Cellubrevin/vesicle-associated membrane protein-3-mediated endocytosis and trafficking regulate platelet functions.

Authors:  Meenakshi Banerjee; Smita Joshi; Jinchao Zhang; Carole L Moncman; Shilpi Yadav; Beth A Bouchard; Brian Storrie; Sidney W Whiteheart
Journal:  Blood       Date:  2017-09-20       Impact factor: 22.113

6.  In vitro and in vivo antiangiogenic properties of the serpin protease nexin-1.

Authors:  Sonia Selbonne; Feriel Azibani; Soria Iatmanen; Yacine Boulaftali; Benjamin Richard; Martine Jandrot-Perrus; Marie-Christine Bouton; Véronique Arocas
Journal:  Mol Cell Biol       Date:  2012-02-13       Impact factor: 4.272

Review 7.  Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug.

Authors:  Annachiara Mitrugno; Joanna L Sylman; Rachel A Rigg; Samuel Tassi Yunga; Joseph J Shatzel; Craig D Williams; Owen J T McCarty
Journal:  Platelets       Date:  2017-12-21       Impact factor: 3.862

Review 8.  Historical perspective and future directions in platelet research.

Authors:  B S Coller
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

9.  Platelets govern pre-metastatic tumor communication to bone.

Authors:  B A Kerr; N P McCabe; W Feng; T V Byzova
Journal:  Oncogene       Date:  2013-09-15       Impact factor: 9.867

10.  Arf6 controls platelet spreading and clot retraction via integrin αIIbβ3 trafficking.

Authors:  Yunjie Huang; Smita Joshi; Binggang Xiang; Yasunori Kanaho; Zhenyu Li; Beth A Bouchard; Carole L Moncman; Sidney W Whiteheart
Journal:  Blood       Date:  2016-01-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.